13 results
Pressors and Inotropes

Norepinephrine
 • alpha1 > beta 1
 • Increase SVR > Inotropy
Vasopressin
 • V1
 •
Pressors and Inotropes ... Increase SVR > Inotropy ... #criticalcare # ... pharmacology #comparison ... #shock #management
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Receptor, Heart Rate/Inotropy ... Dobutamine 2-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management ... #Comparison #Inotropes
Vasopressors Demystified

Shock comes in many flavors and so do vasopressors. Here’s a OnePager summarizing my approach
Vasopressors #Basics #CriticalCare ... #Management #Pharmacology ... #Comparison #Inotropes
Cardiff COVID-19 Daily checklist - Matt Morgan
A daily checklist for critically ill #covid19 patients. Concentrates on
COVID-19 Daily checklist ... Morgan A daily checklist ... Is Norad > 0.5 mcg ... COVID19 #Daily #criticalcare ... #SARSCoV2 #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... 100 cells/mm3 g/mL ... #Treatment #management ... #HIVAIDS #pharmacology
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
Vasopressors and Inotropes ... #Vasopressors #Inotropes ... #management #criticalcare ... #summary #comparison ... #table #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... in HIV-AIDS Preventing ... if MIC<0.12 ug/ml ... #Treatment #management ... #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
patients need inotrope ... then placed on prevention ... differential #algorithm #management ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 4–6 mL ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... , 2 doses (0.5 mL ... #Treatment #management ... #HIVAIDS #pharmacology